A recent article in the Washington Post detailed the current battle around the new Alzheimer’s drug, Aduhelm. The question is whether people with Down syndrome should be given access to a drug with questionable research behind it. The article highlighted the link…
read moreResearchers, including clinicians from the Jérôme Lejeune Institute and the University of Chicago, recently published a paper on the possibility of a link between stress and the onset of dementia in patients with Down syndrome (Ds).
read moreRecent Advances in Research on Down Syndrome
read moreIn March 2018, 21 researchers published a study in the British Journal of Psychiatry called “Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study.” The researchers noted that there have been few studies…
read moreAdvocacy around research is important, especially because Down syndrome is the least funded genetic condition by the National Institutes of Health (NIH).
read moreAging with Down syndrome creates new health challenges. Families are helping each other by sharing what they learn.
read moreIn March 2018, 21 researchers published a study in the British Journal of Psychiatry called “Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study.” The researchers noted that there have been few studies…
read more